跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
tenofovir derivative
首页
药物
tenofovir derivative
tenofovir derivative
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Topical antiviral formulations
US 2006058265 A1
申请人: GILEAD SCIENCES INC
优先权: 2005
CN
US
7 件公开
Hypotonic microbicidal formulations and methods of use
US 10092509 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2015
US
5 件公开
COMBINATION OF ANTI-HIV REVERSE TRANSCRIPTASE AND PROTEASE INHIBITORS
US 2007208009 A1
申请人: HOETELMANS RICHARD MARINUS W
优先权: 2004
CN
US
2 件公开
HYPOTONIC HYDROGEL FORMULATIONS FOR ENHANCED TRANSPORT OF ACTIVE AGENTS AT MUCOSAL SURFACES
EP 3250184 B1
申请人: UNIV JOHNS HOPKINS
优先权: 2015
EP
US
2 件公开
Compound preparation of tenofovir and entecavir and its application against hepatitis B virus
CN 101278938 A
申请人: HEILONGJIANG JIAZHOU INTERNAT
优先权: 2008
CN
Antibodies against tenofovir and derivatives thereof
CN 114761014 A
申请人: ABBOTT RAPID DIAGNOSTICS INT UNLIMITED COMPANY
优先权: 2019
CN
Tenofovir derivative salt, preparation method thereof, and pharmaceutical composition
CN 110746461 A
申请人: JIANGSU KEBEN PHARMACEUTICAL CO LTD
优先权: 2019
CN
Preparation method and application of tenofovir derivative
CN 112358503 A
申请人: NANJING TIANHAI PHARMACEUTICAL TECH CO LTD
优先权: 2020
CN
Long-acting prodrug derivative for controlling in-vivo drug release
CN 117466939 A
申请人: YANTAI INSTITUTE OF MAT MEDICA
优先权: 2023
CN
药物
反馈